BOARD OF ADVISORS

Christopher has 40+ years of leadership in the healthcare, digital health & wellness and insurtech industries. He was VP of Sales at Vida Health, a digital health and wellness company.  Prior to that, he was CEO of the Employee Benefits Practice at Willis Group, overseeing a $500M global P&L with 3,000 employees worldwide.  Chris also held executive leadership positions with large global brands such as Cigna, AIG, and Sequoia Consulting Group.  He was on the Board of Advisors with Cigna, United Health, and GeoBlue.  Chris holds a BA degree from Boston College.

Dr. Doron is a board-certified family physician, obesity physician, clinical lipidologist, and founder of Consonant Consulting. After residency, he served as the sole physician at a newly opened FQHC branch in South Florida, where he helped grow the practice from scratch to a thriving practice in two years, providing much-needed care to the underserved. After building that infrastructure, he spent the next five years at Ro, one of the fastest-growing healthcare startups in the U.S., where he served as Chief Clinical Officer. Dr. Doron’s interests and expertise include digital health, men’s and women’s health, metabolic health, and mental health.

Marc is currently a Managing Partner at Duce Management, LLC, a family office fund that focuses on biotech and digital health firms with intellectual property and platform technology of eventual interest to specialty pharmaceutical manufacturers seeking therapies for cancer. Mr. Duey was the Founder, President, and CEO of ProMetrics, Inc., from 1993 to 2019, a leading patient-level data aggregator, AI-based patient analytics, and service provider to the specialty pharmaceutical industry for over two decades. Prior to founding ProMetrics, Mr. Duey was the founder and President of DuWest Research, an international management consulting firm, that specialized in serving the needs of diagnostic and biotechnology firms. He is an adjunct professor at West Chester University in both the Business School and the Pharmaceutical Product Development program (PPD). He serves on the Board of Trustees of International House Philadelphia and is a member of the Leadership Council of the Wistar Institute, a leading cancer and vaccine research organization. Marc holds a B.S. and an M.S. degree in science from the University of Ottawa, and an M.B.A. from the Ivey Business School at Western University, London, Canada.  

Dr. Kane, is an endocrinology, diabetes & metabolism specialist in West Chester, PA. He has over 38 years of experience in the medical field. Dr. Kane has extensive experience in Gonadal Endocrine Disorders, Metabolic Disorders, and Osteoporosis and screening. He attended St. Joseph’s University, and earned his medical degree from The University of Ottawa in 1984. He completed his residency at Bryn Mawr Hospital in 1987 and completed a fellowship in Endocrinology and Metabolism at Temple University in 1989.

Dr. Kim is the CEO and founding member of the Center for Interventional Pain & Spine with a dozen locations in the Mid-Atlantic region.  He is highly recognized for his specialty in neuromodulation therapies and intrathecal drug delivery systems and functional medicine.  Dr. Kim is passionate about interventional approaches to pain management and increasing the quality of life for his patients.  Dr. Kim began his career at Loyola University Stritch School of Medicine, then completed his residency at the Hospital of the University of Pennsylvania.

Shane is the CEO and co-founder of Dental & Health Management Solution, and the Capital Dental Equipment, and also the founder of AnyPlace MD. Shane held management positions in assisted living and Alzheimer’s memory residential centers.  Shane has served as an advisory board member for Concordia University Texas Heroes.  Shane earned a BS from Texas State University in San Marcos